Abstract
Since decreased serum levels of testosterone (T) do not necessarily predict good outcome of testosterone treatment for erectile disorder, the purpose, of this study was to determine which men with erectile disorder and decreased serum levels might benefit from treatment. From a sample of 31 men(\({\bar x}\) age = 39 years), 15 (48%) with erectile disorder and decreased serum levels of T responded well after 8 weeks of testosterone treatment (100 mg of testosterone propionate in the sustained-release form given im once a week). Good treatment outcome was associated with several variables, but only high levels of luteinizing hormone (LH) and low values of the T/LH (testosterone/LH) ratio consistently emerged as significant correlates and/or predictors of effective treatment. Levels of LH above 7.5 IU/L or the values of the T/LH ratio equal to or below 0.87 nmol/IU in patients with erectile disorder and decreased serum levels of T suggest that testosterone treatment may be effective.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Afifi, A. A., and Clark, V. (1984). Computer-Aided Multivariate Analysis, Lifetime Learning Publications, Belmont, CA.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., rev., American Psychiatric Association, Washington, DC.
Benson, G. S. (1994). Endocrine factors related to impotence. In Bennett, A. H. (ed.), Impotence. Diagnosis and Management of Erectile Dysfunction, W. B. Saunders, Philadelphia, pp. 31–41.
Carani, C., Zini, D., Baldini, A., Della Casa, L., Ghizzani, A., and Marrama, P. (1990). Effects of androgen treatment in impotent men with normal and low levels of free testosterone. Arch Sex. Behav. 19: 223–234.
Davidson, J. M., Chen, J. J., Crapo, L., Gray, G. D., Greenleaf, W. J., and Catania, J. A. (1983). Hormonal changes and sexual function in aging men. J. Clin. Endocrinol. Metab. 57. 71–77.
Gooren, L., and Rubens, R. (1987). Overview of the concept of andropause. In Zichella, L., Whitehead, M., and Van Keep, P. A. (eds.), The Climacteric and Beyond: The Proceedings of the Fifth International Congress on the Menopause, Parthenon Publishing Group, Sorrento, pp. 85–93.
Kinsey, A. C., Pomeroy, W. B., and Martin, C. E. (1948). Sexual Behavior in the Human Male. W. B. Saunders, Philadelphia.
Kwan, M., Greenleaf, W. J., Mann, J., Crapo, Z., and Davidson, J. M. (1983). The nature of androgen action on male sexuality: A combined laboratory-self-report study in hypogonadal men. J. Clin. Endocrinol. Metab. 57: 557–562.
National Institutes of Health. (1992, Dec. 7-9). Impotence. NIH Consensus Statement. 10(4):1–31.
O'Carroll, R., Shapiro, C., and Bancroft, J. (1985). Androgens, behavior and nocturnal erection in hypogonadal men: The effects of varying the replacement dose. Clin. Endocrinol. 23: 527–538.
Skolnick, A. A. (1992). Is “male menopause” real or just an excuse? J. Am. Med. Assoc. 268: 2486.
Vermeulen, A., Rubens, R., and Verdonck, L. (1972). Testosterone secretion and metabolism in male senescence. J. Clin. Endocrinol. Metab. 34: 730–735.
Weinstein, M. C., and Fineberg, H. V. (1990). Structuring clinical decisions under uncertainty. In Weinstein, M. C., and Fineberg, H. V. (eds.), Clinical Decision Analysis, W. B. Saunders, Philadelphia, pp. 61–62.
Werner, A. A. (1939). Male climateric. J. Am. Med. Assoc. 112: 1441–1443.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rakic, Z., Starcevic, V., Starcevic, V.P. et al. Testosterone Treatment in Men with Erectile Disorder and Low Levels of Total Testosterone in Serum. Arch Sex Behav 26, 495–504 (1997). https://doi.org/10.1023/A:1024555805632
Issue Date:
DOI: https://doi.org/10.1023/A:1024555805632